Buscador de publicaciones

Publicaciones

  • Vega-García N, Pérez-Jaume S, Esperanza-Cebollada E, Vicente-Garcés C, Torrebadell-Burriel M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderon CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón M, Muñoz L, Velasco MR, García-Morín M, Català-Temprano A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molinés A, Guerra-Garcia P, Pérez-Martínez A, García-Abós M, Robles R, Pisa S, Adán R, Díaz de Heredia C, José Luis Dapena Díaz, Rives-Sola S, Ramirez M and Camós-Guijosa M.

    Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

    Frontiers in pediatrics . 8: 614521-614521. Nº de citas: 1

    [doi:10.3389/fped.2020.614521]

  • Cuadros M, García DJ, Andrades A, Arenas AM, Coira IF, Baliñas-Gavira C, Peinado P, Rodríguez MI, Álvarez-Pérez JC, Ruiz-Cabello F, Camós-Guijosa M, Jiménez-Velasco A and Medina PP.

    LncRNA-mRNA Co-Expression Analysis Identifies AL133346.1/CCN2 as Biomarkers in Pediatric B-Cell Acute Lymphoblastic Leukemia.

    Cancers . 12(12): 3803.

    [doi:10.3390/cancers12123803]

  • Turrubiartes-Martinez, E, Bodega-Mayor, I, Delgado-Wicke, P, Molina-Jimenez, F, Casique-Aguirre, D, Gonzalez-Andrade, M, Rapado, I, Camós-Guijosa M, Diaz-de-Heredia, C, Barragan, E, Ramirez-Orellana, M, Aguado, B, Figuera, A, Martinez-Lopez, J and Fernandez-Ruiz, E.

    TYK2 Variants in B-Acute Lymphoblastic Leukaemia.

    GENES . 11(12): . Nº de citas: 3

    [doi:10.3390/genes11121434]

  • Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garcés C, Alonso J, Barragán E, Fernández G, Hernández-Sánchez JM, Martín-Izquierdo M, Joan Maynou Fernández, Minguela A, Montaño A, Ortega M, Torrebadell-Burriel M, Cervera J, Sánchez J, Jiménez-Velasco A, Riesco S, Hernández-Rivas JM, Lassaletta Á, Fernández JM, Rives-Sola S, Dapena JL, Ramírez M, Camós-Guijosa M and On Behalf Of The Group Of Leukemia Of The Spanish Society Of Pediatric Hematolog.

    Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia.

    Journal of Personalized Medicine . 10(4): 244.

    [doi:10.3390/jpm10040244]

  • Montano, A, Matorra-Miguel, M, Forero-Castro, M, Lumbreras, E, Santos, S, Miguel, C, Fuster, JL, De las Heras, N, Garcia-de Coca, A, Sierra, M, Davila, J, De la Fuente, I, Olivier, C, Olazabal, J, Martinez, J, Vega-García N, Camós-Guijosa M, Gonzalez, T, Hernandez-Rivas, JM and Benito, R.

    APPLICATION OF A NGS DIAGNOSTIC PANEL TO IMPROVE AND REFINE THE STRATIFICATION OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA B

    HAEMATOLOGICA . 105: 26-26.

  • Zanetti SR, Romecin PA, Vinyoles M, Manel Juan Otero, Fuster JL, Camós-Guijosa M, Querol S, Delgado M and Menendez P.

    Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

    Journal for ImmunoTherapy of Cancer . 8(2): .

    [doi:10.1136/jitc-2020-001419]

  • Molina O, Vinyoles M, Granada I, Roca-Ho H, Gutierrez-Agüera F, Valledor L, López-López CM, Rodríguez-González P, Trincado JL, Tirados-Menéndez S, Pal D, Ballerini P, Den Boer ML, Plensa-Nebot I, Pérez-Iribarne MM, Rodriguez-Perales S, Calasanz MJ, Ramírez M, Rodríguez R, Camós-Guijosa M, Calvo M, Bueno C and Menendez P.

    Impaired Condensin Complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL.

    Blood . 136(3): 313-327. Nº de citas: 6

    [doi:10.1182/blood.2019002538]

  • Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M.

    FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia.

    PHARMACOLOGICAL RESEARCH . 151: 104556-104556. Nº de citas: 2

    [doi:10.1016/j.phrs.2019.104556]

  • Sánchez-Martínez D, Baroni ML, Gutierrez-Agüera F, Roca-Ho H, Blanch-Lombarte O, González-García S, Torrebadell-Burriel M, Junca J, Ramírez-Orellana M, Velasco-Hernández T, Bueno C, Fuster JL, Prado JG, Calvo J, Uzan B, Cools J, Camós-Guijosa M, Pflumio F, Toribio ML and Menéndez P.

    Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia.

    Blood . 133(21): 2291-2304. Nº de citas: 32

    [doi:10.1182/blood-2018-10-882944]

  • Torrebadell-Burriel M, Diaz-Beya M, Kalko SG, Pratcorona M, Nomdedeu J, Navarro A, Gel B, Brunet S, Sierra J, Camós-Guijosa M and Esteve J.

    A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.

    LEUKEMIA & LYMPHOMA . 59(10): 2394-2404. Nº de citas: 7

    [doi:10.1080/10428194.2017.1422859]